Cytodyn Inc (CYDY)

[Saltz]

BLA is #1 priority. They are working as intelligently as they are able with Amarex to make sure Part 2 is successful. Remember the FDA has requested all of the Mono data. That cost money and time. Imperative this section of the BLA is submitted to the FDA’s requirements. I personally believe with my discussions with Craig Eastwood and what I’m hearing from Nader this is not some BS excuse but rather the bottom line.

Cancer Basket Trial is #2 priority. Amarex is blown away that they have 70 patients waiting to be injected. Will have 10 patients injected by the end of February and then hit the road running with Basket Trial in March.

All the focus and resources is on those two areas.